The Australian stocks I'd trust for the next 10 years

It is no surprise that brokers rate these stocks as buys.

| More on:
A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • NextDC is positioned to thrive over the next decade, supported by trends in cloud computing and AI, with its secure and integral data centres creating high barriers to customer exit.
  • ResMed's commanding role in the underdiagnosed sleep apnoea market, bolstered by strong margins and recurring revenue, makes it a promising long-term investment with vast growth potential.
  • TechnologyOne’s shift to a software-as-a-service model ensures recurring revenue and high customer retention, with the potential to triple in size in the coming decade due to its entrenched enterprise systems.

Trying to predict what the share market will do next month or even next year is a tough game.

But looking a decade ahead is often where long-term investors can gain an edge. Over that timeframe, short-term noise fades away and the quality of the underlying business really starts to matter.

So, if I were building a portfolio with a 10-year mindset, here are three Australian stocks that I think could deliver the goods.

NextDC Ltd (ASX: NXT)

NextDC is well-placed to benefit from several unstoppable trends, including cloud computing, artificial intelligence, and the ongoing digitisation of the economy. As more data is created, stored, and processed, demand for high-quality, secure, and well-connected data centres continues to grow.

What makes NextDC particularly compelling is the long-term nature of its customer contracts and the mission-critical role its infrastructure plays. Once a customer is embedded in a data centre ecosystem, switching is costly and complex.

It is no wonder then that the team at Morgans recently upgraded this Australian stock to a buy rating with a $19.00 price target.

ResMed Inc (ASX: RMD)

Another Australian stock to buy and hold for 10 years is ResMed. It has spent decades building a dominant position in sleep apnoea treatment, and the opportunity ahead remains enormous.

There are an estimated one billion people globally suffering from sleep apnoea, with the vast majority undiagnosed. That gives ResMed a massive, underpenetrated market to keep growing into.

With strong margins, recurring revenue, and a global footprint, ResMed has many of the hallmarks of a long-term compounder that can steadily grow earnings over many years.

The team at Macquarie is bullish on its outlook. It has an outperform rating and $49.20 price target on its shares.

TechnologyOne Ltd (ASX: TNE)

Lastly, TechnologyOne could be an Australian stock to buy and hold. It provides enterprise software to governments, councils, and large organisations, sectors that value reliability over experimentation.

Its transition to a software-as-a-service model has delivered highly recurring revenue, strong cash generation, and excellent customer retention. Once embedded, TechnologyOne's systems become deeply integrated into customer operations, making them very sticky. Over a 10-year horizon, that kind of predictable, compounding growth can be incredibly powerful.

In fact, management believes it can double in size every five years. So, if it delivers on this, it could triple in size over the next decade.

UBS is a fan and has a buy rating and $38.70 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Nextdc, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A older man and younger man rest, exhausted but happy after a good boxing session.
Growth Shares

Why these battered ASX shares deserve a second look

These stocks might be bruised, but not down and out.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

3 stellar ASX growth shares that could rise 25% to 50%

Analysts see potential for these shares to deliver big returns for investors.

Read more »

Two plants grow in jars filled with coins.
Growth Shares

2 excellent ASX All Ords stocks I'd buy today

These businesses are far too cheap, in my opinion.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Opinions

2 ASX shares that could turn $100,000 into $1 million

These ASX businesses are well-positioned for great growth over the next few years, and beyond.

Read more »

A group of young people lean over the rails overlooking Sydney's Circular Quay and check out the sights of the city around them.
Growth Shares

3 Aussie stocks to buy and hold forever

There's a reason why I would hold onto these shares for the long haul.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

These ASX shares look cheap and could reward patient investors

At current levels, these cheap stocks offer upside, but patience is required.

Read more »

A group of businesspeople clapping.
Growth Shares

3 Australian stocks that are my best buy and holds for 2026

These three stocks could be destined for big things in the future.

Read more »